We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01578447
First Posted: April 17, 2012
Last Update Posted: September 18, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Society of Family Planning
Bill and Melinda Gates Foundation
Rakai Health Sciences Program
Information provided by (Responsible Party):
Ronald Gray, Johns Hopkins Bloomberg School of Public Health